🇺🇸 FDA
Patent

US 12059413

Methods of inhibiting viruses using compositions targeting TSG101-ubiquitin interaction

granted A61KA61K31/437A61K31/4439

Quick answer

US patent 12059413 (Methods of inhibiting viruses using compositions targeting TSG101-ubiquitin interaction) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Aug 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/437, A61K31/4439, A61P, A61P31/12